SpringWorks Therapeutics, Inc. | Mid-cap | Healthcare
$46.99
0.00%
| SpringWorks Stock Comparison:
SpringWorks vs VertexSpringWorks vs RegeneronSpringWorks vs Blueprint MedicinesSpringWorks vs Roivant SciencesSpringWorks vs Bio-TechneSpringWorks vs S&P 500 | Market
Overview Income Statement Balance Sheet Cash Flow Key Ratios Peer Comparison

Financial Overview

Latest Annual: 2024

Income Metrics

Revenue 191.6M
Gross Profit 179.0M 93.45%
Operating Income -278.1M -145.17%
Net Income -258.1M -134.73%

Balance Sheet Metrics

Total Assets 587.3M
Total Liabilities 106.2M
Shareholders Equity 481.1M
Debt to Equity 0.22

Cash Flow Metrics

Operating Cash Flow -215.1M
Free Cash Flow -196.3M

Revenue & Profitability Trend

SpringWorks Income Statement From 2020 to 2024

Metric20242023202220212020
Revenue191.6M5.4M0035.0M
Cost of Goods Sold12.6M422.0K00-
Gross Profit179.0M5.0M00-
Operating Expenses457.2M348.0M280.7M173.5M81.3M
Operating Income-278.1M-343.0M-280.7M-173.5M-46.3M
Pre-tax Income-258.1M-325.1M-277.4M-173.9M-45.6M
Income Tax-----
Net Income-258.1M-325.1M-277.4M-173.9M-45.6M
EPS (Diluted)--$5.15-$5.21-$3.59-$1.05

Income Statement Trend

SpringWorks Balance Sheet From 2020 to 2024

Metric20242023202220212020
Assets
Current Assets380.5M500.9M599.8M382.9M513.4M
Non-Current Assets206.8M224.9M30.5M69.6M62.8M
Total Assets587.3M725.8M630.2M452.5M576.2M
Liabilities
Current Liabilities100.0M78.2M51.0M30.0M17.6M
Non-Current Liabilities6.2M21.4M21.0M129.0K1.5M
Total Liabilities106.2M99.6M72.0M30.1M19.1M
Equity
Total Shareholders Equity481.1M626.2M558.2M422.4M557.1M

Balance Sheet Composition

SpringWorks Cash Flow Statement From 2020 to 2024

Metric20242023202220212020
Operating Activities
Net Income-258.1M-325.1M-277.4M-173.9M-45.6M
Operating Cash Flow-215.1M-238.6M-179.6M-134.2M-37.4M
Investing Activities
Capital Expenditures-----
Investing Cash Flow85.2M42.1M-205.4M85.6M-418.2M
Financing Activities
Dividends Paid-----
Financing Cash Flow-8.4M296.5M338.7M0269.6M
Free Cash Flow-196.3M-230.2M-171.8M-129.9M-32.8M

Cash Flow Trend

SpringWorks Key Financial Ratios

Valuation Ratios

Forward P/E -21.95
Price to Book 8.44
Price to Sales 16.11
PEG Ratio -21.95

Profitability Ratios

Profit Margin -115.60%
Operating Margin -164.07%
Return on Equity -51.57%
Return on Assets -28.47%

Financial Health

Current Ratio 4.33
Debt to Equity 1.77
Beta 0.70

Per Share Data

EPS (TTM) -$3.41
Book Value per Share $5.57
Revenue per Share $2.95

Peer Financial Comparison

CompanyMarket CapP/E RatioP/B RatioROEProfit MarginDebt/Equity
swtx3.5B-8.44-51.57%-115.60%1.77
Vertex 114.1B32.826.92-5.64%-8.91%10.00
Regeneron 55.3B13.021.8415.96%31.94%9.20
Blueprint Medicines 8.3B-120.0024.19-47.71%-27.70%208.50
Roivant Sciences 7.8B1.951.71-12.54%96.86%1.93
Bio-Techne 7.9B60.873.926.53%10.89%20.99

Financial data is updated regularly. All figures are in the company's reporting currency.